STOCK TITAN
  1. Home
  2. Sec-filings
  3. CME
  4. [8-K] CME GROUP INC. Reports Material Event

CME Group (CME) outlines client pricing changes via Special Executive Report

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

CME Group Inc. reports that on August 11, 2026 it communicated pricing changes to its clients through Special Executive Report No. 9799, with the notice made available on the company’s website. The disclosure is presented under Regulation FD to ensure broad, non-selective dissemination of this information.

The report also identifies Exhibit 104 as the cover page formatted in Inline XBRL, supporting electronic data use and compliance with SEC technical requirements.

Positive

  • None.

Negative

  • None.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Communication date August 11, 2026 Date pricing changes were communicated to clients via Special Executive Report No. 9799
Exhibit number 104 Cover page formatted in Inline XBRL identified as Exhibit 104
Special Executive Report No. 9799 Identifier for the report used to communicate pricing changes to clients
Regulation FD regulatory
"The information is furnished under Item 7.01, Regulation FD Disclosure"
Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.
Special Executive Report financial
"communicated pricing changes to its clients via Special Executive Report No. 9799"
Inline XBRL technical
"The cover page from CME Group Inc.’s ... formatted in Inline XBRL"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

What did CME (CME) disclose about pricing changes on August 11, 2026?
CME Group Inc. disclosed that it communicated pricing changes to clients on August 11, 2026 via Special Executive Report No. 9799, and posted the related notice on its website for broader access.

How were CME (CME) pricing changes communicated to clients?
CME Group Inc. states that pricing changes were communicated via Special Executive Report No. 9799 and that a copy of this notice was posted on the company’s website for client and public reference.

Under which SEC item did CME (CME) present the pricing change information?
The pricing change information is furnished under Item 7.01, Regulation FD Disclosure, meaning it is intended to provide fair disclosure and is not deemed filed for liability purposes under Section 18 of the Exchange Act.

Is the CME (CME) pricing notice incorporated into other SEC filings?
CME Group Inc. states the information furnished under Item 7.01 is not deemed incorporated by reference in Securities Act or Exchange Act filings unless specifically referenced in a future filing.

What is Exhibit 104 in CME’s (CME) August 11, 2026 report?
Exhibit 104 is identified as the cover page formatted in Inline XBRL, providing a machine-readable version of the cover information consistent with SEC electronic reporting requirements.

Who signed CME’s (CME) August 11, 2026 pricing disclosure report?
The report was signed on behalf of CME Group Inc. by Lynne Fitzpatrick, Senior Managing Director, President and Chief Financial Officer, who is identified as the Principal Financial Officer and duly authorized officer.
false0001156375false000115637500011563752026-08-112026-08-1100011563752026-06-092026-06-09

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549 
_________________________________________________________
FORM 8-K
 
_________________________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) August 11, 2026 (August 11, 2026)
 
 _________________________________________________________
CME GROUP INC.
(Exact Name of Registrant as Specified in its Charter) 
_________________________________________________________ 
Delaware001-3155336-4459170
(State or Other Jurisdiction
of Incorporation)		(Commission
File No.)		(IRS Employer
Identification No.)
 
20 South Wacker DriveChicagoIllinois60606
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code: (312) 930-1000
N/A
(Former Name or Former Address, if Changed Since Last Report) 
______________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbolName of each exchange on which registered
Class A Common StockCMENasdaq
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐






Item 7.01. Regulation FD Disclosure.

On August 11, 2026, CME Group Inc. communicated pricing changes to its clients via Special Executive Report No. 9799. A copy of this notice has been posted to the Company’s website.

The information furnished under Item 7.01 of this report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information furnished under Item 7.01 of this report shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.


Item 9.01. Financial Statements and Exhibits.

Exhibit
Number     Description
104     The cover page from CME Group Inc.’s Current Report on Form 8-K, formatted in Inline XBRL.









SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
CME Group Inc.
Registrant
Date: August 11, 2026By:/s/ Lynne Fitzpatrick
Name:
Title:
Lynne Fitzpatrick
Senior Managing Director, President and Chief Financial Officer

Principal Financial Officer and Duly Authorized Officer










Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents